Navigation Links
Phidea Srl and Marvin Research Srl Announce Completion of Merger
Date:1/22/2009

MILAN, Italy, January 22 /PRNewswire/ -- Phidea S.r.l. a full service and leading clinical research organization (CRO), today announced that it has completed the merger with Marvin Research S.r.l., a CRO focused on Phase I to Phase IV clinical trials.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080122/335477 )

The new company will be named Phidea Marvin S.r.l. and have legal and operating offices in Milan, Italy. The combined company will also continue to operate its offices in Madrid, Spain providing drug development services to companies in need of a single source for clinical research including design and management of pan-European clinical trials (Phase I - III), and post marketing studies (Phase IV). Services offered by the new company will include all aspects of the clinical trial process including: protocol design, regulatory affairs, site selection, clinical monitoring, data management, statistical analysis and medical writing. Observational and epidemiological studies will also continue to be performed.

Phidea Marvin specializes in cardiovascular, CNS, gastroenterology oncology, rheumatology and anti-infective studies and services a broad range of multinational pharmaceutical firms.

Vincenzo Cocuzza, M.D., Phidea-Marvin's Chief Executive Officer stated, "We believe that this combination broadens our client base even further then it was, and provides the necessary platform for growth. We have a compelling strategy to expand operations into global markets and especially the United States and will continue to look for strategic opportunities that allow us to realize our goals. The merger with Marvin moves us closer to our objectives by:

    - Adding a partner with a strong market position and reputation in
      specific therapeutic areas

    - Adding additional multinational customers

    - Reducing costs

    - Increasing the overall size of the organization to allow even larger
      studies to be performed.

We also believe that the Marvin and Phidea teams have built an impressive portfolio of accomplishments and will work together to become a leader in the CRO sector."

About Phidea S.r.l.

Phidea S.r.l. specializes in international clinical research. The firm was founded in 1982 in Milan, Italy. In 1991 it expanded its operations and organized its Spanish subsidiary, Phidea Spain, in Madrid, Spain. The firm and partners provide a complete range of services to pharmaceutical companies including product formulation, stability, clinical trial material manufacturing, and all phases of clinical research.

Staffed with renown scientist and medical doctors, Phidea services major pharmaceutical companies seeking premium research in the European Union.

About Marvin Research S.r.l.

Marvin Research was founded in January 1999 by Vincenzo Maresca, M.D., with a team of experts from several CROs. Based in Milan, Italy, the firm focuses on Phase I through Phase IV human clinical trials for multinational pharmaceutical companies. Marvin Research's services span the entire clinical program including preparation of protocols by medical experts, all aspects of monitoring and performance of the trial, and finally statistics and report generation.

    Phidea Marvin Management Team.

    Vincenzo Cocuzza, Chairman and CEO
    Vincenzo Maresca, Managing Director
    Aldo Cocuzza, Managing Director

    For more information regarding Phidea Marvin S.r.l. contact:

    Mr. Aldo Cocuzza, Director,
    +39-3939189389 or email at aldo.cocuzza@phideamarvin.com

    Phidea-Marvin S.r.l.
    International Clinical Research
    Via Cristoforo Colombo, 1.
    Corsico (Milan, Italy)




'/>"/>
SOURCE Phidea Marvin Srl
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
2. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
3. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
4. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
5. Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinsons Disease Research
6. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
7. 2008 Human Research Protection Award Recipients Announced
8. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
9. K-State Researcher Finds Correlation Between Childhood Obesity and Asthma
10. Myeloperoxidase Research Expands
11. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 ... company advancing technologies designed to address rare, emerging ... Chitra Edwin , Ph.D., RAC, as Senior ... Edwin will provide leadership for all U.S. and ... approvals, preparation of regulatory submissions, serving as the ...
(Date:12/7/2016)...  Urinary catheters are used for patients suffering ... disorders. Urinary catheters include indwelling (Foley) catheter, intermittent ... Foley catheter is a flexible tube with lumens ... inserted into the bladder through the urethra and ... at one end of the catheter is inflated ...
(Date:12/7/2016)... , Dec. 7, 2016  Palatin Technologies, ... has closed on a previously disclosed underwritten public ... Canaccord Genuity acted as sole book-running manager, Roth ... Capital Markets acted as co-manager for the offering. ... $15.4 million in net proceeds, allowing us to ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... and deep lines by smoothing and tightening the skin of the face to ... to address facial aging with very little downtime, Silhouette Instalift is a novel, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... women growing up with a schizophrenic mother in a unique, personal perspective through ... specializes in treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning of October ... emergency medical call when he lost control of his patrol car. The vehicle overturned ... vehicle, he was transported to Atlanta Medical Center, where he later succumbed to his ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Castle Dermatology ... in several ways to restore a more youthful appearance to the face. Dr. Peyman ... Sculptra, along with a variety of other treatments, to rejuvenate and renew the facial ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
Breaking Medicine News(10 mins):